Novel strategy for small cell lung cancer treatment prompts clinical trial
New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint known as the G1/S checkpoint. ...
Aug 20, 2025
0
41








